The effects of Morus alba, Cinnamomum verum, Gymnema sylvestre, pyridoxine, and zinc on blood glucose

Evaluation of the effects of drug preparation containing "Morus alba, Cinnamomum verum, Gymnema sylvestre, pyridoxine, and zinc" in the control of blood glucose in patients with type 2 diabetes mellitus: a randomized double-blind placebo-controlled clinical trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150721023282N32

Enrollment

Registered

2026-05-08

Start date

2026-08-11

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabet melitus. Type 2 diabetes mellitus

Interventions

Intervention 1: Intervention group: Glycosin oral tablet, twice daily, for 8 weeks. Intervention 2: Control group: Placebo oral tablet, twice daily, for 8 weeks.

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age between 18 and 60 years old Diagnosis of type 2 diabetes according to ADA criteria Glycosylated hemoglobin (HbA1c) between 7 and 9%

Exclusion criteria

Exclusion criteria: Using alcohol and other substances which cab be abused Pregnancy Lactation

Design outcomes

Primary

Measure	Time frame
Fasting Blood Glucose. Timepoint: Before and After Intervention. Method of measurement: Laboratory Test.;HgbA1C. Timepoint: Before and After Intervention. Method of measurement: HPLC test.	—

Secondary

Measure	Time frame
HOMA-IR. Timepoint: Before and After Intervention. Method of measurement: Using the formula.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRasool Soltani

Esfahan University of Medical Sciences

soltani@pharm.mui.ac.ir+98 31 3786 5537

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026